Skip to content

Efficacy Analysis of Personalized-Target Transcranial Magnetic Stimulation (TMS) in the Treatment of Chronic Tinnitus

Efficacy Analysis of Personalized-Target Transcranial Magnetic Stimulation (TMS) in the Treatment of Chronic Tinnitus: A Single-Center, Single-Blind Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118003
Enrollment
Unknown
Registered
2026-01-30
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus

Interventions

experimental group:The experimental group underwent fMRI functional connectivity analysis to precisely identify the functional node in the left auditory cortex that exhibited the strongest connectivit
control group:In the control group, the stimulation target was determined according to the anatomical landmarks of the international 10–20 EEG system, corresponding to the left CP5 electrode site (ant

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients presenting primarily with tinnitus: individuals experiencing subjective auditory perceptions in the ear or deep within the head in the absence of internal or external sound stimuli. 2. Chronic tinnitus patients with a duration of =6 months, Tinnitus Handicap Inventory (THI) score =38, and unresponsive to conventional pharmacological treatment. 3. Patients able to undergo a continuous 5-day cTBS treatment course and who are outpatients at Sun Yat-sen Memorial Hospital, Sun Yat-sen University. 4. Tinnitus frequency ranging from 125 to 8000 Hz. 5. Age between 18 and 70 years.

Exclusion criteria

Exclusion criteria: 1. Patients with conductive hearing loss, a history of middle ear surgery, pulsatile tinnitus caused by vascular malformations, or tinnitus associated with Ménière’s disease. 2. History of head trauma, central nervous system disorders, psychiatric disorders, or substance abuse. 3. Pregnancy.

Design outcomes

Primary

MeasureTime frame
Effective rate of chronic tinnitus relief;

Secondary

MeasureTime frame
Change in tinnitus loudness;Change in anxiety symptoms;Change in depressive symptoms;Change in sleep quality;Effective rate of tinnitus relief during intervention and follow-up;

Countries

China

Contacts

Public ContactYuexin Cai

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

caiyx25@mail.sysu.edu.cn+86 188 1888 8888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026